Evidence map›Paper›PMID 22722205›Full record

ArticleNature2012

Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets.

Masaki Imai, Tokiko Watanabe, Masato Hatta, Subash C Das, Makoto Ozawa, Kyoko Shinya, Gongxun Zhong, Anthony Hanson, Hiroaki Katsura, Shinji Watanabe and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Nature, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 895 papers.

0numbers the graph read from it
0cells of the map it votes in
895citing papers in PubMed
138.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

895 citing papers in PubMed, 1,545 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. A multimodaliScience · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

835 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 2 countries.

Masaki ImaiDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin 53711, USA.
Tokiko Watanabe
Masato Hatta
Subash C Das
Makoto Ozawa
Kyoko Shinya
Gongxun Zhong
Anthony Hanson
Hiroaki Katsura
Shinji Watanabe
Chengjun Li
Eiryo Kawakami
Shinya Yamada
Maki Kiso
Yasuo Suzuki
Eileen A Maher
Gabriele Neumann
Yoshihiro Kawaoka
University of Wisconsin–Madison · USThe University of Tokyo · JPChubu University · JPKobe University · JPNational Institute of Infectious Diseases · JPTokyo University of Science · JP

Funding

Transmissibility of avian influenza viruses in mammalsR01AI069274 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KAWAOKA, YOSHIHIRO · 2006 to 2016
$5.5M
Virology Training ProgramT32AI078985 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI LAMBERT, PAUL F. · 2009 to 2018
$3.3M
NIAID NIH HHS R01 AI069274NIAID NIH HHS T32 AI078985
6 · The paper itself

Abstract

Highly pathogenic avian H5N1 influenza A viruses occasionally infect humans, but currently do not transmit efficiently among humans. The viral haemagglutinin (HA) protein is a known host-range determinant as it mediates virus binding to host-specific cellular receptors. Here we assess the molecular changes in HA that would allow a virus possessing subtype H5 HA to be transmissible among mammals. We identified a reassortant H5 HA/H1N1 virus-comprising H5 HA (from an H5N1 virus) with four mutations and the remaining seven gene segments from a 2009 pandemic H1N1 virus-that was capable of droplet transmission in a ferret model. The transmissible H5 reassortant virus preferentially recognized human-type receptors, replicated efficiently in ferrets, caused lung lesions and weight loss, but was not highly pathogenic and did not cause mortality. These results indicate that H5 HA can convert to an HA that supports efficient viral transmission in mammals; however, we do not know whether the four mutations in the H5 HA identified here would render a wholly avian H5N1 virus transmissible. The genetic origin of the remaining seven viral gene segments may also critically contribute to transmissibility in mammals. Nevertheless, as H5N1 viruses continue to evolve and infect humans, receptor-binding variants of H5N1 viruses with pandemic potential, including avian-human reassortant viruses as tested here, may emerge. Our findings emphasize the need to prepare for potential pandemics caused by influenza viruses possessing H5 HA, and will help individuals conducting surveillance in regions with circulating H5N1 viruses to recognize key residues that predict the pandemic potential of isolates, which will inform the development, production and distribution of effective countermeasures.

Indexed as

Adaptation, PhysiologicalAnimalsBioterrorismBirdsBody FluidsCell LineDogsEvolution, MolecularFemaleFerretsHEK293 CellsHeLa CellsHemagglutinin Glycoproteins, Influenza VirusHot TemperatureHumansInfluenza A Virus, H1N1 SubtypeHemagglutinin Glycoproteins, Influenza VirusReceptors, Virus

Identifiers

PMID22722205
PMCPMC3388103
OpenAlexW2112170460

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.